Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. J Clin Oncol. 2011 Mar 01; 29(7):825-31.
View in:
PubMed
subject areas
Adult
Adult
Biopsy, Needle
Biopsy, Needle
Choriocarcinoma
Choriocarcinoma
Dactinomycin
Dactinomycin
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Administration Schedule
Female
Female
Follow-Up Studies
Follow-Up Studies
Gestational Trophoblastic Disease
Gestational Trophoblastic Disease
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Injections, Intramuscular
Injections, Intramuscular
Injections, Intravenous
Injections, Intravenous
Logistic Models
Logistic Models
Maximum Tolerated Dose
Maximum Tolerated Dose
Medical Oncology
Medical Oncology
Methotrexate
Methotrexate
Neoplasm Staging
Neoplasm Staging
Odds Ratio
Odds Ratio
Ontario
Ontario
Pregnancy
Pregnancy
Pulse Therapy, Drug
Pulse Therapy, Drug
Treatment Outcome
Treatment Outcome
Young Adult
Young Adult
authors with profiles
Robert S Mannel